Key result
Generic rosuvastatin demonstrates effective lipid-lowering potency and tolerability in high-risk cardiovascular patients.
Answers are grounded in this paper and cite their sources.
Reports on the lipid-lowering efficacy and tolerability of generic rosuvastatin in high-risk patients, indicating its role in reducing cardiovascular risk.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nikolay Runev (2014) studied this question. Generic rosuvastatin was evaluated for its lipid-lowering potency and tolerability in Bulgarian patients with high and very high cardiovascular risk.
Synapse has enriched 10 related papers. Consider them for comparative context: